NOVA Biologics

What NOVA Biologics does

NOVA Biologics, Inc. is a privately held, FDA-registered specialty distributor of biologic raw material intermediates, founded in 2006 and headquartered in Oceanside, California. The company operates as an authorized global distributor — not a manufacturer — supplying Human Serum Albumin (HSA) excipient and diagnostic grades, Bovine Serum Albumin (BSA), and human plasma and serum (including disease-state and processed variants) to clinical laboratories, academic and private research organizations, pharmaceutical manufacturers, and in-vitro diagnostic (IVD) manufacturers. Its supply base is anchored by three core OEM partnerships: Octapharma AG (FDA/EMA-certified HSA from U.S.-sourced plasma), Bio Products Laboratory Ltd. (MHRA-licensed cGMP HSA), and Bovogen Biologicals (ISO 9001:2015 and ISO 13485:2018 BSA, manufactured via a proprietary two-step purification and heat-shock process and EDQM CEP R1 CEP 2005 293 Rev 02). The proprietary manufacturing technology — including BovoStar and BovoTech BSA production and BPL's chromatography polishing step for HSA — sits with NOVA's partners rather than NOVA itself.

Commercially, NOVA runs a hybrid go-to-market combining an e-commerce storefront (novabiologics.com) for credit-card SMB and individual orders with a direct, consultative sales motion involving account managers and inside-sales support for enterprise accounts, purchase orders, and restricted products (HSA requires licensure verification). Pricing is quote-based, payment terms are NET 30 on POs with ACH/wire/check, credit cards accepted only via the website, and a $65 hazmat fee applies to dry-ice shipments. Unit economics are characterized by low-ticket specialty raw materials (e.g., BSA at $52–$570, HSA at $130–$260 per unit), implying revenue accumulates through volume rather than transaction size. NOVA's value proposition is centered on regulatory documentation stewardship — Certificates of Analysis, MSDS, BSE/TSE statements, GMP certification, Plasma Master File Letters of Access — supplied on behalf of its manufacturing partners to support customer drug and diagnostic filings. The company has continuously operated for over two decades with no disclosed external funding, M&A, or leadership turnover in available sources.

Name

NOVA Biologics

Legal name

NOVA Biologics Inc.

Website

https://novabiologics.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

NOVA Biologics is a privately held, FDA-registered specialty distributor supplying Human Serum Albumin, Bovine Serum Albumin, and human plasma/serum raw material intermediates to clinical laboratories, research organizations, and pharmaceutical and IVD manufacturers globally.

Ownership category

akta.pro rank

Product category

Biological Raw Materials

SIC

Biological Products, (No Disgnostic Substances) (2836), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Biologics & Biosimilars Distributors (HLAIAJAH)

Keywords

• Biological raw materials
• Serum albumin products
• Pharmaceutical excipients
• Diagnostic reagents
• Biologic intermediates

Headquarters

HQ city

Oceanside

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Biologic Raw Material Product Sales: NOVA Biologics generates revenue through the one-time sale of biologic raw material intermediates including Human Serum Albumin (HSA), Bovine Serum Albumin (BSA), Human Plasma & Serum, and Human Protein Fractions. Products are sold directly to customers with NET 30 payment terms for purchase orders. Credit card payments are accepted only through the website for online orders. HSA is restricted and requires licensure for purchase.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

NOVA Biologics is an authorized distributor of biologic raw material intermediates, including Bovine Serum Albumin (BSA), Human Serum Albumin (HSA), human plasma and serum, and human protein fractions. Products are sourced from GMP-certified manufacturers (Bovogen Biologicals, Octapharma, and Bio Products Laboratory) and sold to clinical laboratories, research organizations, and pharmaceutical and in-vitro diagnostic (IVD) manufacturers globally. The company supports customers with regulatory documentation (CoA, MSDS, BSE/TSE statements, GMP certification) required for drug and diagnostic product approvals.

Product overview

NOVA Biologics is a global provider of biologic raw material intermediates, operating as a single-product focused company rather than a platform-plus-modules architecture. The product portfolio centers on human and animal-derived biologic raw materials for clinical laboratories, research organizations, pharmaceutical and in-vitro diagnostic manufacturers. Core product lines include: (1) Bovine Serum Albumin products - BovoStar Premium BSA and BovoTech Technical Grade BSA sourced from Australian/New Zealand origin; (2) Human Serum Albumin (HSA) - spanning excipient-grade (Octapharma and BPL sourced, FDA/EU/MHRA approved) and diagnostic-grade (liquid and lyophilized) variants; (3) Human Protein Fractions including HSA Diagnostic and Human Gamma Globulin (HGG) Diagnostic; (4) Human Plasma & Serum - Normal including Source Plasma, Recovered Plasma, and Processed Serum variants (Charcoal Stripped, Defibrinated, Delipidized); (5) Human Plasma & Serum - Disease State for autoimmune, infectious disease, and tumor marker applications. Products serve cell culture, IVD, and pharmaceutical manufacturing end uses.

Differentiator

Problem solved

Functional benefit

Brands

• BovoStar: Premium Bovine Serum Albumin (BSA) product line manufactured using proprietary two-step purification/heat shock process by Bovogen Biologicals.
• BovoTech

Products and services

• BovoStar Premium BSA Premium Bovine Serum Albumin (BSA) of Australian and New Zealand origin, manufactured using a proprietary two-step purification and heat shock process by Bovogen Biologicals. Used in cell culture, protein studies, diagnostic assays, vaccine production, and as blocking agents in immunoassays for research and IVD manufacturers.
• BovoTech BSA - Technical Grade High-performance technical grade Bovine Serum Albumin engineered for precision in-vitro and diagnostic applications. Used by IVD manufacturers and research laboratories in ELISA, Western blot, PCR, RIA, flow cytometry, and chemiluminescence workflows.
• Human Serum Albumin (HSA) Excipient, USP/EP - Octapharma FDA and EU approved biologic injectable Human Serum Albumin manufactured by Octapharma using US-sourced human plasma, meeting US and European Pharmacopeia specifications. Used as an excipient and stabilizer in pharmaceutical and biologic product manufacturing, drug delivery, cryopreservation, and cell culture. Restricted product requiring licensure for purchase.
• BPL Human Serum Albumin (HSA) Excipient, USP/EP FDA/EU and MHRA approved Human Serum Albumin manufactured by Bio Products Laboratory (BPL) for excipient use. Manufactured under cGMP from US-sourced plasma with dual stabilizers (caprylate and acetyltryptophanate). Used as a stabilizer, carrier molecule for drug delivery, medical device coating, and in nanoparticle albumin-bound formulations.
• Human Serum Albumin (HSA) Diagnostic - Liquid Diagnostic grade Human Serum Albumin in liquid form, used as a stable protein base, diluent, and in cell culture applications. Provided as filtered bulk liquid or sterile filled product of US origin, tested per FDA regulations.
• Human Serum Albumin (HSA) Diagnostic - Lyophilized Diagnostic grade Human Serum Albumin in lyophilized (powder) form, used as a stable protein base, diluent, or excipient. Provides batch-to-batch consistency with full traceability, with custom manufacturing available.
• Human Gamma Globulin (HGG) Diagnostic - Liquid Human Gamma Globulin (immunoglobulin) made from human plasma containing antibodies. Used as a cell culture nutrient or as an IgG spike for in-vitro diagnostics. Material is of US origin and tested per FDA regulations.
• Human Plasma, Source Source plasma collected via plasmapheresis in FDA licensed facilities in the United States. Tested negative for antibodies to HIV and HCV, nonreactive for HBsAg, HIV-1 RNA, and HCV RNA, with donors tested for syphilis per FDA guidelines.
• Human Plasma, Recovered Recovered plasma derived from whole blood. Each donation tested negative/nonreactive for HBsAg, HBV, HIV-1, HCV, WNV, and antibodies to HIV-1/2, HCV, HTLV I/II, HbC, syphilis, and T. cruzi (Chagas), and negative for Zika by investigational NAT.
• Human Serum - Charcoal Stripped Processed human serum in which hormones, vitamins, and other proteins are removed using activated charcoal. Available in single, double charcoal stripped, and custom manufactured forms. Derived from plasma collected in US FDA licensed blood collection facilities.
• Human Serum - Defibrinated, Delipidized Defibrinated human serum with delipidized treatment using fumed silica and dextran sulfate. Custom manufacturing available upon request.
• Human Serum - Defibrinated Defibrinated human serum derived from human plasma by processing with chemicals that cause the plasma to clot. Custom manufacturing available upon request.
• Human Plasma and Serum - Disease State Wide range of human disease state plasma and serum products available in bulk plasma units and individual patient samples. Includes autoimmune antibodies, infectious disease markers, tumor markers, immunoglobulins, and allergen-specific IgE. All material is ethically collected with associated donor data including age, gender, ethnicity, medications, test method, test result, and diagnosis.

Quantifiable outcome

• 5-year shelf life for BovoStar BSA products
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Bovogen Biologicals Pty LtdcoreChannel Partner/ Reseller/ DistributorNOVA Biologics is the authorized distributor for 'BovoStar' premium AU & NZ Origin Bovine Serum Albumin (BSA) manufactured by Bovogen Biologicals. Bovogen Biologicals, based in Melbourne, Australia, is a subsidiary of ANZCO Foods (New Zealand). Their BSA is manufactured using a proprietary two-step purification/heat shock process in a fully validated protein manufacturing facility under strict GMP conditions. The product features include low endotoxin, ultra high purity, ultra low immunoglobulin, ultra low fatty acid content, and batch-to-batch consistency.
• Octapharma AGcoreChannel Partner/ Reseller/ DistributorNOVA Biologics is the authorized distributor of Human Serum Albumin (HSA), USP/EP manufactured by Octapharma to the global market. Octapharma's FDA, EMA, and GMP certified facilities in the US manufacture HSA using only US-sourced human plasma. NOVA works with Octapharma's regulatory, quality, and technical representatives to support customers' documentation needs from R&D to commercial approval. HSA meets US and European Pharmacopeia specifications.
• Bio Products Laboratory Ltd. (BPL)coreChannel Partner/ Reseller/ DistributorNOVA Biologics is the authorized distributor of Human Serum Albumin for excipient use, USP/EP manufactured by Bio Products Laboratory Ltd. (BPL) to the global market. BPL's state-of-the-art manufacturing facility in Elstree, UK operates under cGMP and undergoes regular inspections by UK MHRA and international regulatory agencies. HSA is manufactured using US-sourced plasma from FDA-regulated and PPTA-approved collection centers, with dual stabilizers (caprylate and acetyltryptophanate). BPL products meet US, EU, and Chinese Pharmacopoeial monographs.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/nova-biologics-inc.

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NOVA Biologics